Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech, Inc.
Esohe Ekinaduese Idusogie
Michael George Mulkerrin
Leonard G. Presta
Robert Laird Shields
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/054,255external-prioritypatent/US6242195B1/en
Application filed by Genentech, Inc., Esohe Ekinaduese Idusogie, Michael George Mulkerrin, Leonard G. Presta, Robert Laird ShieldsfiledCriticalGenentech, Inc.
Priority claimed from CA2323757Aexternal-prioritypatent/CA2323757C/fr
Publication of CA2577543A1publicationCriticalpatent/CA2577543A1/fr
Application grantedgrantedCritical
Publication of CA2577543CpublicationCriticalpatent/CA2577543C/fr
A method of dissolving a cell or inhibiting cell growth, a bispecific molecule that binds FNT-1R and an SAF antibody, a medical preparation that contains it and its use